Maynard Um
-
-
-
-
-
-
-
Revolution Medicines prices RASONQUE at $39,800 per month
-
-
-
-
-
-
-
Revolution Medicines, Inc. (RVMD) Misses Q2 EPS by 110c
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Revolution (RVMD) Following Trial Data Release
-
-
-
-
-
-
-
Bernstein SocGen Group Starts Revolution (RVMD) at Market Perform
-
-
-
-
-
-
-
Revolution (RVMD) PT Raised to $185 at Mizuho
-
-
-
-
-
-
-
Revolution (RVMD) PT Raised to $200 at Evercore ISI
-
-
-
-
-
-
-
Revolution (RVMD) Reiterated at Buy by Stifel Ahead of Numerous Stock-Moving Events
-
447,698 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

